Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Current Assets (2020 - 2026)

Cytek Biosciences filings provide 6 years of Current Assets readings, the most recent being $392.0 million for Q4 2025.

  • On a quarterly basis, Current Assets fell 1.12% to $392.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $392.0 million, a 1.12% decrease, with the full-year FY2025 number at $392.0 million, down 1.12% from a year prior.
  • Current Assets hit $392.0 million in Q4 2025 for Cytek Biosciences, up from $388.5 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $454.0 million in Q4 2022 to a low of $216.9 million in Q2 2021.
  • Median Current Assets over the past 5 years was $396.4 million (2024), compared with a mean of $401.9 million.
  • Biggest five-year swings in Current Assets: surged 106.95% in 2021 and later dropped 13.65% in 2023.
  • Cytek Biosciences' Current Assets stood at $431.7 million in 2021, then increased by 5.16% to $454.0 million in 2022, then fell by 13.65% to $392.1 million in 2023, then increased by 1.12% to $396.4 million in 2024, then dropped by 1.12% to $392.0 million in 2025.
  • The last three reported values for Current Assets were $392.0 million (Q4 2025), $388.5 million (Q3 2025), and $382.8 million (Q2 2025) per Business Quant data.